Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

USFDA nod to Padcev plus Keytruda for certain patients with Bladder cancer: Pfizer, Astellas Pharma

Pfizer to acquire Seagen for USD 43 billion

Ruchika Sharma14 March 2023 12:00 PM IST

The proposed acquisition is also expected to enable for combination potential across both the Seagen and Pfizer pipelines and will leverage Pfizer's...

Lupin secures SBTi validation for emission reduction targets

Lupin gets zero USFDA observations for Bioresearch Centre in Pune

Ruchika Sharma14 March 2023 11:07 AM IST

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed an inspection of...

Lupin Partners with TB Alliance to Advance Telacebec for TB, Leprosy and Buruli Ulcer

Mylab Discovery Solutions, DnaNudge ink pact for development of next-generation molecular diagnostics for diabetic foot infections

Ruchika Sharma13 March 2023 4:57 PM IST

DnaNudge's new multiplex tests will enable health teams to quickly identify the specific microbiological organisms responsible for each foot...

Sanofi to acquire Provention Bio for USD 2.9 billion

Ruchika Sharma13 March 2023 3:30 PM IST

Paris: Sanofi and Provention Bio, Inc have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

KEYTRUDA plus chemotherapy improves overall survival versus chemotherapy alone to treat advanced malignant pleural mesothelioma: Merck

Ruchika Sharma13 March 2023 2:27 PM IST

Malignant mesothelioma is a type of cancer that starts in the linings of certain parts of the body, including the chest, abdomen, heart and testicles.

Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE Mark

USFDA Committee votes in favour of clinical benefit of Roche's Polivy combination for people with previously untreated diffuse large B- cell lymphoma

Ruchika Sharma13 March 2023 1:15 PM IST

Polivy is a first-in-class anti-CD79b antibody-drug conjugate.

Centre should regulate manufacturing of drugs instead of state bodies, new bill moots

Ruchika Sharma13 March 2023 12:05 PM IST

The proposed bill provides for regulation of clinical trials of new drugs, investigational new drugs, the ethics committee etc.

Alembic Pharma wins USFDA nod for heart disease drug

Alembic Pharma successfully completes USFDA inspection for Derma Facility at Karakhadi

Ruchika Sharma13 March 2023 11:05 AM IST

Vadodara: Alembic Pharma has announced that the company has successfully completed the United States Food and Drug Administration (USFDA) inspection...

Novartis opens new radioligand therapy manufacturing facility in California

Novartis launches new USD 11 billion share buyback

Ruchika Sharma13 March 2023 10:00 AM IST

Zurich: Novartis has formally launched its new share buyback programme where it could spend up to 10 billion Swiss francs ($10.90 billion)...

USFDA nod to Zydus Eluxadoline tablets for irritable bowel syndrome with diarrhoea

Zydus bags USFDA nod for Olanzapine Orally Disintegrating Tablets to treat certain mental conditions

Ruchika Sharma12 March 2023 3:30 PM IST

These tablets belong to a class of drugs called as atypical antipsychotics and work by helping to restore the balance of certain natural substances in...

GSK, Pfizer ready to launch RSV vaccines for older adults in US

Ruchika Sharma12 March 2023 2:30 PM IST

RSV is a leading cause of pneumonia in infants and the elderly, and decades of research have finally resulted in the two successful vaccines Pfizer...

Moderna loses bid to shift liability in COVID vaccine patent case

Ruchika Sharma12 March 2023 1:15 PM IST

Despite the backing of the U.S. government, Moderna Inc on Friday failed to persuade a federal judge it should not have to face a patent lawsuit...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok